Xanthelasmas are yellowish or tan-colored bumps that form on the eyelids, most commonly appearing on the inner corner near the nose. The term comes from two Greek words: "xanthos" (yellow) and "elasma" (plate or sheet). These deposits are collections of cholesterol and lipids that accumulate under the skin in this sensitive area. Unlike a pimple or common skin growth, xanthelasmas represent a buildup of fatty substances that have migrated beneath the skin's surface over months or years.
Learn About Paying Your FGUA Bill Online →
The condition occurs when cholesterol particles, particularly low-density lipoprotein (LDL) cholesterol, deposit themselves in the dermis—the layer of skin beneath the outer surface. This happens because the skin around the eyes is extremely thin and delicate, making it more susceptible to lipid accumulation. Xanthelasmas are not contagious, not cancerous, and do not pose an immediate threat to vision or eye health. However, their presence often signals something important happening in your body's cholesterol metabolism.
Research shows that roughly 4 to 8 percent of the general population develops xanthelasmas at some point. The condition appears more frequently in individuals over 40, though younger people can develop it too. People of Mediterranean, Asian, and African descent report higher rates of xanthelasma formation. One study published in the American Journal of Epidemiology found that about 50 percent of people with xanthelasmas have elevated cholesterol levels, meaning the visible eyelid deposits are often just the tip of a larger metabolic issue.
Key takeaway: Xanthelasmas are cholesterol deposits under the eyelid skin that typically develop gradually over time. Seeing them on your own eyelids is a signal to consider getting your cholesterol and overall cardiovascular health evaluated.
The eyes are not random landing spots for excess cholesterol. The area around your eyelids has unique characteristics that make it particularly vulnerable to lipid deposits. The skin here is among the thinnest on your entire body—roughly half the thickness of skin on your cheeks. This thinness means there's less barrier between the blood vessels and the surface, making it easier for cholesterol particles to escape from circulation and accumulate in the tissue.
Free Guide to Pay by Plate Illinois Billing →
Additionally, the eyelid region has relatively few oil glands and limited blood circulation compared to other facial areas. This combination means that once cholesterol particles settle there, they tend to stay put. The body doesn't easily mobilize and remove these deposits the way it might in other locations. Think of it like a traffic jam: cholesterol particles get stuck in a low-traffic area and simply pile up over time.
The primary driver behind xanthelasma formation is elevated blood cholesterol, particularly high LDL cholesterol and low HDL cholesterol. However, not everyone with high cholesterol develops xanthelasmas, and some people with apparently normal cholesterol levels do develop them. This variation depends on individual genetics, how efficiently your body processes lipids, and whether you have certain metabolic conditions. People with familial hypercholesterolemia—a genetic disorder affecting cholesterol metabolism—have especially high rates of xanthelasma development, sometimes appearing as young as in their 20s or 30s.
Other contributors to xanthelasma formation include diabetes, thyroid disease, and systemic inflammation. Some medications that raise cholesterol levels, such as certain blood pressure drugs or corticosteroids, can increase your risk. Lifestyle factors like diet high in saturated fats, sedentary behavior, and smoking all contribute to the cholesterol levels that eventually deposit around the eyes.
Key takeaway: Xanthelasmas form because the eyelid area has thin skin with limited blood flow, creating an ideal environment for cholesterol to accumulate. The underlying cause is usually elevated cholesterol in your bloodstream, but genetics and metabolic conditions play significant roles.
Xanthelasma development typically follows a predictable progression, though the timeline varies from person to person. In the earliest stage, you might notice a very small yellowish bump or slight discoloration on the inner eyelid. Many people initially mistake these for a stye or minor irritation. The deposits are usually painless and cause no itching or tenderness, though some individuals report mild pressure or fullness in the eyelid area.
Free Guide to Mold Removal Methods for Walls →
As xanthelasmas grow, they become more noticeable in appearance. The bumps may spread across the eyelid or develop in multiple spots, sometimes forming on both eyes symmetrically. The color typically ranges from pale yellow to orange-brown. The texture is usually soft and slightly raised, though some deposits become firmer over time. In advanced cases, xanthelasmas can grow large enough to affect eyelid function slightly, though complete vision obstruction is extremely rare.
The development timeline is highly individual. Some people develop small xanthelasmas over 5-10 years with minimal change. Others see more rapid growth, particularly if their cholesterol remains elevated or metabolic conditions worsen. People who catch their high cholesterol early and manage it through medication and lifestyle changes often see their xanthelasmas stabilize or even shrink slightly.
Unlike many skin conditions, xanthelasmas don't typically appear suddenly or change rapidly overnight. This gradual nature is actually useful for monitoring—if you notice your eyelid deposits growing noticeably within weeks, it's worth discussing with your healthcare provider, as it may indicate that your cholesterol management needs adjustment. Photograph your eyelids periodically if you've noticed xanthelasmas; this creates a useful reference for tracking changes over months and years.
Key takeaway: Xanthelasmas typically develop slowly over months or years as small yellowish bumps on the inner eyelids. Their gradual development makes them suitable for monitoring at home, and sudden changes warrant a conversation with your healthcare provider.
If you've noticed xanthelasmas, your healthcare provider will likely want to check your cholesterol levels if they haven't recently. The presence of xanthelasmas is considered a marker of potential cardiovascular risk, even in some cases where standard cholesterol tests show only moderately elevated numbers. Research published in BMJ found that people with xanthelasmas had significantly higher rates of heart disease and stroke compared to those without these deposits, independent of their measured cholesterol levels.
How to Delete Your Fitbit Account Guide →
This connection exists because xanthelasmas indicate that your body is actively depositing lipids in tissue, suggesting your cholesterol particles may be abnormal in composition or that your body isn't processing them efficiently. Some people with xanthelasmas have what's called "pattern B" LDL cholesterol—smaller, denser particles that penetrate tissue more easily and pose greater cardiovascular risk than larger LDL particles. Standard cholesterol tests don't measure this distinction, but xanthelasmas themselves can signal its presence.
Several important cholesterol values become particularly relevant when xanthelasmas are present. Total cholesterol above 200 mg/dL is considered elevated. LDL cholesterol (the "bad" cholesterol) should ideally be below 100 mg/dL, with lower being better for those at cardiovascular risk. HDL cholesterol (the "good" cholesterol) should be above 40 mg/dL for men and above 50 mg/dL for women. Triglycerides, another blood fat, should stay below 150 mg/dL. Having xanthelasmas suggests closer monitoring of all these values may be warranted.
Beyond standard cholesterol screening, xanthelasmas may prompt your provider to order additional tests. Lipoprotein(a) is a genetic variation of LDL cholesterol that increases cardiovascular risk; elevated lipoprotein(a) is found in many people with xanthelasmas. Your provider might also evaluate apolipoprotein B, which measures the total number of harmful cholesterol particles in your blood, a potentially more useful measure than LDL cholesterol alone for risk assessment.
Key takeaway: Xanthelasmas should trigger a thorough cholesterol evaluation including LDL, HDL, triglycerides, and potentially advanced measures like lipoprotein(a) and apolipoprotein B, as they indicate a higher cardiovascular risk
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.